Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iOCT-guided treatment of diabetic macular edema during vitrectomy
NCT05138029Phase 3Unknown
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Antibody Fragments, Antibody Conjugates, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab, dexamethasone in diabetic macular edema (DME), sponsored by Affiliated Hospital of Nantong University. Status: unknown.
02
Drugs
ranibizumabdexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05138029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138029.